What is RxWare?
RxWare offers a secure, AI-driven platform designed to simplify patient access to healthcare services through HIPAA-compliant tools for enrollment, messaging, consents, and surveys. Their solutions cater to specialty pharma programs and clinical trials, focusing on enhancing patient engagement, treatment adherence, and workflow optimization. Target clients include specialty clinics, infusion centers, and pharmaceutical brands facing challenges with compliance and patient dropout. The RxWare Operating System integrates seamlessly with existing healthcare infrastructures to provide a unified patient experience while ensuring regulatory compliance.
How much funding has RxWare raised?
RxWare has raised a total of $6.1M across 1 funding round:
Private Equity
$6.1M
Private Equity (2025): $6.1M, investors not publicly disclosed
What's next for RxWare?
The recent major strategic investment signals a new phase of growth and expansion for RxWare. This capital infusion is expected to accelerate the development of its AI-driven platform, enhance its market penetration within specialty pharma and clinical trials, and further solidify its position as a leader in patient access solutions. The company is poised to leverage this backing to deepen its integration capabilities and expand its service offerings, addressing critical needs in patient engagement and regulatory compliance.
See full RxWare company page
